Showing 1 of 1 recruiting trials for “Proximal Xq28 duplication syndrome”
A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR RNA-editing Therapy in Patients with Mecp2 Duplication Syndrome, a Rare Orphan Disease (HERO)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →